Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer

Por V. B. Matveev, A. A. Kirichek, A. V. Savinkova, A. V. Khachaturyan, D. A. Golovina, L. N. Lyubchenko
Publicado em 2018-12-01

THE HPV STATUS IN BLADDER CANCER, TUMOR MORPHOLOGICAL CHARACTERISTICS, AND CLINICAL FEATURES OF THE DISEASE

Por D. A. Golovina, V. D. Ermilova, A. V. Khachaturyan, N. L. Cheban, V. B. Matveev, G. M. Volgareva
Publicado em 2014-03-01

Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome

Por A. V. Semyanikhina, N. I. Pospekhova, M. G. Filippova, D. A. Golovina, A. O. Rasulov, L. N. Lyubchenko
Publicado em 2019-12-01

THE HPV STATUS IN BLADDER CANCER, TUMOR MORPHOLOGICAL CHARACTERISTICS, AND CLINICAL FEATURES OF THE DISEASE

Por D. A. Golovina, V. D. Ermilova, A. V. Khachaturyan, N. L. Cheban, V. B. Matveev, G. M. Volgareva
Publicado em 2014-07-01

SPECTRUM OF SOMATIC MUTATIONS IN RETROPERITONEAL LEIOMYOSARCOMA: CLINICAL CASE AND LITERATURE REVIEW

Por V. E. Bugaev, M. P. Nikulin, D. A. Golovina, V. M. Safronova, S. N. Nered, L. N. Lyubchenko, I. S. Stilidi
Publicado em 2020-09-01

Molecular biological subtypes of breast cancer in BRCA1 mutation carriers

Por N. I. Pospekhova, D. A. Golovina, M. G. Filippova, A. V. Semyanikhina, S. L. Dranko, A. M. Danishevich, A. M. Stroganova
Publicado em 2021-01-01

HUMAN PAPILLOMAVIRUS AS A RISK FACTOR FOR BLADDER CANCER

Por G. M. Volgareva, G. A. Frank, D. A. Golovina, L. E. Zavalishina, Yu. Yu. Andreyeva, A. V. Khachaturyan, N. L. Cheban, V. B. Matveev
Publicado em 2010-12-01

HUMAN PAPILLOMAVIRUS AS A RISK FACTOR FOR BLADDER CANCER

Por G. M. Volgareva, G. A. Frank, D. A. Golovina, L. E. Zavalishina, Yu. Yu. Andreyeva, A. V. Khachaturyan, N. L. Cheban, V. B. Matveev
Publicado em 2014-08-01